Literature DB >> 9457831

Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy.

C Charra1, P Roy, R Coquard, P Romestaing, J M Ardiet, J P Gérard.   

Abstract

PURPOSE: To describe an original brachytherapy technique using a dedicated intravaginal template for the treatment of vaginal vault recurrences and to evaluate the results of such a treatment. METHODS AND MATERIALS: Between 1978 and 1993, 78 patients with isolated recurrence of cervical or endometrial carcinoma located in the vaginal vault have been treated in Lyon. Initial treatment was surgery alone in 49 cases and irradiation with surgery in 37 cases. Treatment of the vaginal recurrence was performed with interstitial Iridium 192 brachytherapy combined with pelvic external beam radiation therapy in 34 patients. The tumor was implanted with a dedicated intravaginal plastic template. Six parallel metallic needles were implanted in the vaginal vault and afterloaded with Iridium 192 wires of 4 to 6 cm long. The mucosa of the upper half of the vagina received the same dose as the one encompassing the tumor on the 85% isodose of the Paris system.
RESULTS: At 5 years the local control rate was 70% and the overall survival rate 56%. Grade 3 complications occurred in 10% of the cases and only in patients who had received irradiation during the initial treatment of the primary tumor.
CONCLUSIONS: This brachytherapy technique makes it possible to perform Iridium 192 implants in a difficult situation with a favorable long-term control rate and an acceptable rate of complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457831     DOI: 10.1016/s0360-3016(97)00576-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results.

Authors:  Sylvain Dewas; Jean Emmanuel Bibault; Xavier Mirabel; Philippe Nickers; Bernard Castelain; Thomas Lacornerie; Hajer Jarraya; Eric Lartigau
Journal:  Radiat Oncol       Date:  2011-06-23       Impact factor: 3.481

2.  High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.

Authors:  Mio Nakata; Ken Yoshida; Taiju Shimbo; Nobuhiko Yoshikawa; Hiroto Yoshioka; Akihiro Hori; Chikara Sato; Yasuo Uesugi; Yuhei Kogata; Koji Masui; Naoya Murakami; Tairo Kashihara; Hironori Akiyama; Nikolaos Tselis; Masahide Ohmichi; Keiji Nihei
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

3.  Modified Houdek vault applicator for high-dose-rate brachytherapy: a technical report and case series.

Authors:  Revathy Krishnamurthy; Lavanya Gurram; Yogesh Ghadi; Dheera Aravindhan; Libin Scaria; Satish Kohle; Sudarshan Kadam; Supriya Chopra; Umesh Mahantshetty
Journal:  J Contemp Brachytherapy       Date:  2021-12-30

Review 4.  Re-Irradiation for Recurrent Cervical Cancer: A State-of-the-Art Review.

Authors:  Zongyan Shen; Ang Qu; Ping Jiang; Yuliang Jiang; Haitao Sun; Junjie Wang
Journal:  Curr Oncol       Date:  2022-07-25       Impact factor: 3.109

5.  Use of a Flexible Inflatable Multi-Channel Applicator for Vaginal Brachytherapy in the Management of Gynecologic Cancer.

Authors:  Samuel M Shin; Tamara L Duckworth; Benjamin T Cooper; John P Curtin; Peter B Schiff; J Keith DeWyngaert; Stella C Lymberis
Journal:  Front Oncol       Date:  2015-09-14       Impact factor: 6.244

6.  Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer.

Authors:  Shuhei Sekii; Naoya Murakami; Tomoyasu Kato; Ken Harada; Mayuka Kitaguchi; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yoshinori Ito; Ryohei Sasaki; Jun Itami
Journal:  J Contemp Brachytherapy       Date:  2017-05-18

Review 7.  Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer.

Authors:  Valentina Lancellotta; György Kovács; Luca Tagliaferri; Elisabetta Perrucci; Giuseppe Colloca; Vincenzo Valentini; Cynthia Aristei
Journal:  Biomed Res Int       Date:  2018-01-21       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.